Madrigal Pharmaceuticals
MDGL
MDGL
77 hedge funds and large institutions have $266M invested in Madrigal Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
17% less capital invested
Capital invested by funds: $320M → $266M (-$53.8M)
35% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 20
Holders
77
Holding in Top 10
1
Calls
$4.83M
Puts
$4.29M
Top Buyers
| 1 | +$26.2M | |
| 2 | +$3.14M | |
| 3 | +$2.03M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.78M |
| 5 |
CCA
Catalyst Capital Advisors
Huntington,
New York
|
+$1.72M |
Top Sellers
| 1 | -$15M | |
| 2 | -$12.7M | |
| 3 | -$11M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$3.8M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$3.09M |